Literature DB >> 23016491

Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages.

S Manivannan1, Narayan V Rao, V D Ramanathan.   

Abstract

Mycobacterium tuberculosis-specific antibodies possess immunomodulatory effects during tuberculosis infection. Prior sensitization to environmental mycobacteria is known to suppress immune responses against BCG and M. tuberculosis. Mycobacteria-induced antibodies can influence events such as complement activation and phagocytosis during infectious process. In the present study role of anti-M. tuberculosis IgG (anti-M. tb IgG) antibody during interaction between M. tuberculosis and human macrophages mediated through complement has been examined in vitro. Anti-M. tb IgG antibody significantly enhanced complement activation by M. tuberculosis. Phagocytosis of M. tuberculosis by macrophages increased significantly in the presence of complement and/or antibody. Moreover, antibody enhanced phagocytosis in the presence of complement. Addition of antibody alone or in combination with complement also augmented intracellular viability of bacilli within macrophages. Results of this study showed that anti-mycobacterial antibody enhances complement activation and anti-M. tb IgG antibody probably modulates effects of complement during early stages of tuberculosis infection.

Entities:  

Mesh:

Year:  2012        PMID: 23016491

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  14 in total

Review 1.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 2.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

Review 3.  Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

Review 4.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

5.  The effect of maternal helminth infection on maternal and neonatal immune function and immunity to tuberculosis.

Authors:  Dawit Gebreegziabiher; Kassu Desta; Girmay Desalegn; Rawleigh Howe; Markos Abebe
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

6.  A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.

Authors:  Alice Minhinnick; Iman Satti; Stephanie Harris; Morven Wilkie; Sharon Sheehan; Lisa Stockdale; Zita-Rose Manjaly Thomas; Raquel Lopez-Ramon; Ian Poulton; Alison Lawrie; Samantha Vermaak; Alexandre Le Vert; Judith Del Campo; Fergal Hill; Paul Moss; Helen McShane
Journal:  Vaccine       Date:  2016-02-05       Impact factor: 3.641

Review 7.  Antibodies and tuberculosis.

Authors:  Ashley J Jacobs; Juthathip Mongkolsapaya; Gavin R Screaton; Helen McShane; Robert J Wilkinson
Journal:  Tuberculosis (Edinb)       Date:  2016-08-26       Impact factor: 3.131

8.  Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis.

Authors:  Xuezhi Wang; Shuangshuang Chen; Yongjuan Xu; Huajun Zheng; Tongyang Xiao; Yuqing Li; Xing Chen; Mingxiang Huang; Haifeng Zhang; Xijing Fang; Yi Jiang; Machao Li; Haican Liu; Kanglin Wan
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

9.  Mycobacterium tuberculosis Binds Human Serum Amyloid A, and the Interaction Modulates the Colonization of Human Macrophages and the Transcriptional Response of the Pathogen.

Authors:  Malwina Kawka; Anna Brzostek; Katarzyna Dzitko; Jakub Kryczka; Radosław Bednarek; Renata Płocińska; Przemysław Płociński; Dominik Strapagiel; Justyna Gatkowska; Jarosław Dziadek; Bożena Dziadek
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

10.  A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.

Authors:  Sharon Sheehan; Stephanie A Harris; Iman Satti; David A Hokey; Veerabadran Dheenadhayalan; Lisa Stockdale; Zita-Rose Manjaly Thomas; Alice Minhinnick; Morven Wilkie; Samantha Vermaak; Joel Meyer; Matthew K O'Shea; Maria Grazia Pau; Isabella Versteege; Macaya Douoguih; Jenny Hendriks; Jerald Sadoff; Bernard Landry; Paul Moss; Helen McShane
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.